Skip to main content
. Author manuscript; available in PMC: 2022 Feb 1.
Published in final edited form as: Brain Res. 2020 Dec 23;1752:147222. doi: 10.1016/j.brainres.2020.147222

Figure 6.

Figure 6.

Entinostat treatment attenuated hematoma volume on day 3 post-ICH. To assess hematoma volume, the brain hemoglobin content and SW-MRI were performed at 72 h post-ICH as described in methods. Entinostat treatment significantly reduced the (A) ipsilateral brain hemoglobin content (ICH+ vehicle; n=3 and ICH+ Entinostat; n=4) and (B&C) hematoma volume as assessed by SW-MRI (n= 4/group).